Global /India /Healthcare /Drug Manufacturers - General /ONYX

Onyx Biotec Ltd.

ONYX

• NSE: ONYX • Delayed

32.70INR 1.4%

0.3463 USD

As of 20 June 2026, Onyx Biotec Ltd. has a market cap of $6.28M USD, ranking #43550 globally and #3685 in India. It ranks #3864 in the Healthcare sector, and #1245 in the Drug Manufacturers - General industry.

Global Rank

43550

Country Rank

3685

Sector Rank

3864

Industry Rank

1245

Key Stats

Market Cap

$6.28MUSD

592.92M INR

Enterprise Value

$7.18MUSD

678.32M INR

Revenue (TTM)

$7.03MUSD

663.87M INR

EBITDA (TTM)

$593.39KUSD

56.03M INR

Net Income (TTM)

$113.16KUSD

10.68M INR

EBITDA Margin

8.4%

Profit Margin

1.6%

PE Ratio

50.5

PS Ratio

0.9

PB Ratio

1.1

EV/EBITDA

12.1

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Harsh Mahajan open_in_new

Employees

357

Founded

2005

Website

onyxbiotec.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
1.4%	-4.7%	0.2%	-5.1%	-20%	-21%	-38%	-31%	-31%

News

Markets

Exchange	Ticker	Price	Quotes
National Stock Exchange of India (NSE) MIC: XNSE PRIMARY	ONYX Onyx Biotec Ltd ISIN: INE0WVU01018 Shares Out.: Shares Outstanding: 18.132M¹ TV: TradingView: NSE: ONYX SA: Stock Analysis: NSE: ONYX YF: Yahoo Finance: ONYX.NS GF: Google Finance: NSE: ONYX BA: Barron's: ONYX MS: Morningstar: XNSE: ONYX	32.70 INR	TV: TradingView: NSE: ONYX SA: Stock Analysis: NSE: ONYX YF: Yahoo Finance: ONYX.NS GF: Google Finance: NSE: ONYX BA: Barron's: ONYX MS: Morningstar: XNSE: ONYX

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Onyx Biotec Ltd.

Onyx Biotec Limited develops, manufactures, and distributes generic and proprietary pharmaceutical products in India and internationally. The company offers water for injections (WFI), dry powder injections, and dry powder syrup. It also exports its products. Onyx Biotec Limited was incorporated in 2005 and is based in Chandigarh, India.

Similar Companies

Industry: Drug Manufacturers - General (India)

Name	Market Cap (USD) diff.	PE	Country
Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA	$45.22B 4.27T INR 720K%	39.1	India
Divi's Laboratories Ltd. NSE: DIVISLAB	$18.38B 1.73T INR 292K%	70.0	India
Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM	$15.17B 1.43T INR 241K%	63.0	India
Dr. Reddy's Laboratories Ltd. NSE: DRREDDY	$11.73B 1.11T INR 187K%	19.6	India
Mankind Pharma Ltd. NSE: MANKIND	$9.87B 931.67B INR 157K%	52.2	India
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE	$9.71B 916.53B INR 154K%	18.6	India

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 12M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 9M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 6M%	97.4	United States
Roche Holding AG SIX: RO	$318.3B 256.25B CHF 5M%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$284.64B 215.59B GBP 5M%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 4M%	15.1	United States

chevron_leftBack